NCCN Guidelines® Insights: Breast Cancer, Version 4.2023

• DOI: 10.6004/jnccn.2023.0031
• Publication Date: 2023-06-12T19:35:45Z
• Authors: William J. Gradishar; Meena S. Moran; Jame Abraham; Vandana Abramson; Rebecca Aft; Doreen Agnese; Kimberly H. Allison; Bethany Anderson; Harold J. Burstein; Helen Chew; Chau Dang; Anthony D. Elias; Sharon H. Giordano; Matthew P. Goetz; Lori J. Goldstein; Sara A. Hurvitz; Rachel C. Jankowitz; Sara H. Javid; Jairam Krishnamurthy; A. Marilyn Leitch; Janice Lyons; Joanne Mortimer; Sameer A. Patel; Lori J. Pierce; Laura H. Rosenberger; Hope S. Rugo; Bryan Schneider; Mary Lou Smith; Hatem Soliman; Erica M. Stringer...; Melinda L. Telli; Mei Wei; Kari B. Wisinski; Jessica S. Young; Kay Yeung; Mary A. Dwyer; Rashmi Kumar
• Keywords: Clinical Practice; Systemic therapy; Clinical Oncology

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer address all aspects of management breast cancer. treatment landscape metastatic cancer is evolving constantly. therapeutic strategy takes into consideration tumor biology, biomarkers, and other clinical factors. Due to the growing number options, if one option fails, there usually another line therapy available, providing meaningful improvements survival. This Insights report focuses on recent updates specific systemic recommendations patients with stage IV (M1) disease.